Healthcare provider profile · identity verified

Tad Daniel Scheri, M.D.

Family Practice · PITTSBURGH, PA · NPI 1336136373

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	920	263
Lisinopril	Lisinopril	484	145
Amlodipine Besylate	Amlodipine Besylate	458	131
Levothyroxine Sodium	Levothyroxine Sodium	445	112
Hydrochlorothiazide	Hydrochlorothiazide	298	88
Metoprolol Succinate	Metoprolol Succinate	267	72
Pantoprazole Sodium	Pantoprazole Sodium	249	73
Simvastatin	Simvastatin	221	62
Losartan Potassium	Losartan Potassium	193	58
Tamsulosin Hcl	Tamsulosin Hcl	183	61
Metformin Hcl	Metformin Hcl	180	57
Metoprolol Tartrate	Metoprolol Tartrate	180	53
Eliquis	Apixaban	153	43
Irbesartan	Irbesartan	149	46
Gabapentin	Gabapentin	142	41
Omeprazole	Omeprazole	141	45
Furosemide	Furosemide	134	47
Jardiance	Empagliflozin	127	32
Xarelto	Rivaroxaban	120	21
Escitalopram Oxalate	Escitalopram Oxalate	118	40
Rosuvastatin Calcium	Rosuvastatin Calcium	112	44
Lorazepam	Lorazepam	111	42
Atenolol	Atenolol	109	31
Metformin Hcl Er	Metformin Hcl	105	30
Pravastatin Sodium	Pravastatin Sodium	104	32
Sertraline Hcl	Sertraline Hcl	103	30
Clopidogrel	Clopidogrel Bisulfate	96	25
Meloxicam	Meloxicam	94	32
Ezetimibe	Ezetimibe	92	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	84	26
Allopurinol	Allopurinol	83	26
Duloxetine Hcl	Duloxetine Hcl	80	22
Synthroid	Levothyroxine Sodium	80	22
Citalopram Hbr	Citalopram Hydrobromide	76	20
Trazodone Hcl	Trazodone Hcl	72	26
Carvedilol	Carvedilol	66	19
Clonazepam	Clonazepam	66	11
Montelukast Sodium	Montelukast Sodium	64	22
Potassium Chloride	Potassium Chloride	63	22
Alendronate Sodium	Alendronate Sodium	61	21
Ozempic	Semaglutide	61	16
Alprazolam	Alprazolam	59	18
Albuterol Sulfate Hfa	Albuterol Sulfate	58	29
Fluticasone Propionate	Fluticasone Propionate	58	17
Donepezil Hcl	Donepezil Hcl	57	13
Bupropion Xl	Bupropion Hcl	56	15
Finasteride	Finasteride	56	19
Spironolactone	Spironolactone	50	13
Glimepiride	Glimepiride	47	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	15
Tramadol Hcl	Tramadol Hcl	47	13
Olmesartan Medoxomil	Olmesartan Medoxomil	43	11
Famotidine	Famotidine	42	15
Oxycodone Hcl	Oxycodone Hcl	42	16
Bupropion Hcl Sr	Bupropion Hcl	40	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	39	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	13
Januvia	Sitagliptin Phosphate	33	suppressed
Buspirone Hcl	Buspirone Hcl	32	11
Valsartan	Valsartan	32	suppressed
Azithromycin	Azithromycin	30	22
Clonidine Hcl	Clonidine Hcl	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Prednisone	Prednisone	24	16
Celecoxib	Celecoxib	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	11
Azelastine Hcl	Azelastine Hcl	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Methylprednisolone	Methylprednisolone	20	20
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	19	suppressed
Topiramate	Topiramate	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Primidone	Primidone	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Comfort Ez Pen Needle	Pen Needle, Diabetic	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Nuplazid	Pimavanserin Tartrate	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Terbinafine Hcl	Terbinafine Hcl	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Novolin R Flexpen	Insulin Regular, Human	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Repaglinide	Repaglinide	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error